Biologics demand a different level of regulatory attention, and our expertise in regulatory affairs for biologics products ensures that every step meets the required standards. From product characterization and comparability studies to post-market obligations, each step is bound by region-specific protocols. At Artixio, we work closely with companies developing monoclonal antibodies, vaccines, cell and gene therapies, or biosimilars, offering regulatory guidance shaped by science, precision, and country requirements.